Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

ADPT
Adaptive Biotechnologies CorporationUS flagNASDAQ Global Select
17.53
USD
+0.75
- -
2.81BMarket Cap

Income Statement (USD)

MCPAPIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
38
56
85
98
154
185
170
179
277
+ Sales & Services Revenue
38
56
85
98
154
185
170
179
277
- Cost of Revenue
16
20
22
23
49
58
76
72
71
+ Cost of Goods & Services
16
20
22
23
49
58
76
72
71
Gross Profit
23
36
63
76
105
127
95
107
206
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
66
86
141
229
314
328
296
262
263
+ Selling, General & Admin
33
45
69
111
170
184
173
158
167
+ Research & Development
32
39
71
116
142
142
122
103
94
+ Other Operating Expense
2
2
2
2
2
2
2
2
2
Operating Income (Loss)
-44
-50
-78
-153
-209
-200
-202
-155
-57
- Non-Operating (Income) Loss
-1
-3
-10
-7
-2
- -
24
4
2
+ Interest Expense, Net
-2
-3
-10
-7
-2
- -
-2
-3
2
+ Interest Expense
- -
- -
- -
- -
- -
4
14
12
12
- Interest Income
2
3
10
7
2
4
16
15
9
+ Other Non-Op (Income) Loss
1
- -
- -
- -
- -
- -
25
7
- -
Pretax Income
-43
-46
-69
-146
-207
-200
-225
-160
-59
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-43
-46
-69
-146
-207
-200
-225
-160
-59
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-43
-46
-69
-146
-207
-200
-225
-159
-60
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-43
-46
-69
-146
-207
-200
-225
-159
-59
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-43
-46
-69
-146
-207
-200
-225
-159
-59
EBIT
-44
-50
-78
-153
-209
-200
-202
-155
-57
EBITDA
-38
-44
-71
-144
-195
-179
-179
-136
-39
EBITDA Margin (%)
-98.42
-78.61
-82.99
-146.72
-126.35
-96.74
-105.34
-76.05
-14.19
EBITA
-44
-50
-78
-153
-209
-200
-202
-155
-57
Gross Margin (%)
59.22
64.67
73.82
77.1
68.06
68.75
55.63
59.72
74.24
Operating Margin (%)
-113.49
-89.39
-92.15
-155.33
-135.39
-108.03
-118.4
-86.81
-20.62
Profit Margin (%)
-111.4
-83.44
-80.65
-148.63
-134.3
-108.03
-132.29
-89.12
-21.48
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
6
6
8
8
14
21
22
19
18
Basic Weighted Avg Shares
106
106
69
131
140
143
144
147
152
Basic EPS, GAAP
-0.4
-0.44
-0.99
-1.11
-1.48
-1.4
-1.56
-1.08
-0.39
Basic EPS from Cont Ops
-0.4
-0.44
-0.99
-1.11
-1.48
-1.41
-1.56
-1.08
-0.39
Diluted Weighted Avg Shares
106
106
69
131
140
143
144
147
152
Diluted EPS, GAAP
-0.4
-0.44
-0.99
-1.11
-1.48
-1.4
-1.56
-1.08
-0.39
Diluted EPS from Cont Ops
-0.4
-0.44
-0.99
-1.11
-1.48
-1.41
-1.56
-1.08
-0.39

Balance Sheet (USD)

MCPAPIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
205
181
613
727
403
562
410
284
300
+ Cash, Cash Equivalents & STI
192
165
577
688
353
498
346
222
227
+ Cash & Cash Equivalents
85
55
97
123
139
90
65
48
70
+ ST Investments
107
110
480
565
214
408
281
174
156
+ Accounts & Notes Receiv
6
5
13
10
17
40
38
42
50
+ Accounts Receivable, Net
6
5
13
10
17
40
38
42
50
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
5
8
9
14
19
14
14
8
10
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
5
8
9
14
19
14
14
8
10
+ Other ST Assets
3
3
14
15
13
9
11
11
13
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
157
152
300
390
521
294
251
256
213
+ Property, Plant & Equip, Net
14
19
60
139
173
164
120
94
75
+ Property, Plant & Equip
23
32
78
163
209
219
194
182
171
- Accumulated Depreciation
9
12
18
24
36
54
73
88
96
+ LT Investments & Receivables
9
- -
105
119
217
- -
- -
34
13
+ LT Investments
9
- -
105
119
217
- -
- -
34
13
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
134
133
134
132
131
130
131
128
125
+ Total Intangible Assets
134
133
131
129
127
126
124
122
121
+ Goodwill
119
119
119
119
119
119
119
119
119
+ Other Intangible Assets
15
14
12
10
9
7
5
3
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
3
3
3
4
7
5
4
Total Assets
362
333
912
1,116
923
857
661
539
513
+ Payables & Accruals
3
4
9
16
13
21
16
15
14
+ Accounts Payable
2
2
4
3
3
8
8
7
6
+ Accrued Taxes
- -
- -
2
2
- -
- -
- -
- -
1
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
3
2
11
9
12
9
8
7
+ ST Debt
- -
- -
- -
4
5
9
9
10
9
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
4
5
9
9
10
9
+ Other ST Liabilities
18
18
69
85
96
80
62
72
67
+ Deferred Revenue
14
13
61
73
80
64
49
56
45
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
4
6
8
12
16
16
14
17
22
Total Current Liabilities
21
23
78
105
114
110
88
98
90
+ LT Debt
- -
- -
37
104
107
99
89
79
70
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
37
104
107
99
89
79
70
+ Other LT Liabilities
566
568
226
164
99
184
175
160
128
+ Accrued Liabilities
4
7
226
164
99
59
45
27
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
562
561
- -
- -
- -
125
131
132
127
Total Noncurrent Liabilities
566
568
263
268
205
283
265
239
198
Total Liabilities
587
591
341
373
319
393
353
337
288
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
25
38
936
1,254
1,324
1,387
1,453
1,506
1,582
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
25
38
936
1,254
1,324
1,387
1,453
1,506
1,582
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-249
-296
-365
-512
-719
-919
-1,144
-1,304
-1,363
+ Other Equity
- -
- -
1
1
-1
-4
- -
- -
- -
Equity Before Minority Interest
-225
-258
571
743
604
464
308
203
219
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
6
Total Equity
-225
-258
571
743
604
464
308
202
225
Total Liabilities & Equity
362
333
912
1,116
923
857
661
539
513
Shares Outstanding
121
123
125
138
141
143
145
148
154
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
37
108
112
108
99
89
79
Net Debt
-85
-55
-97
-123
-139
-90
-65
-48
-70
Net Debt to Equity
37.98
21.32
-16.91
-16.61
-23.02
-19.4
-21.11
-23.67
-31.33
Tangible Common Equity Ratio
-157.29
-195.27
56.33
62.2
59.89
46.29
34.3
19.21
26.61
Current Ratio
9.77
7.93
7.82
6.91
3.54
5.12
4.66
2.89
3.34
Cash Conversion Cycle
- -
121.07
127.54
178.54
133.92
123.7
115.26
97.84
72.93

Cash Flow Statement (USD)

MCPAPIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-43
-46
-69
-146
-207
-200
-225
-160
-59
+ Depreciation & Amortization
6
6
8
8
14
21
22
19
18
+ Non-Cash Items
8
10
11
29
57
67
93
63
53
+ Stock-Based Compensation
7
11
13
25
43
55
63
54
51
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
27
9
1
+ Other Non-Cash Adj
- -
-1
-2
4
14
12
3
- -
1
+ Chg in Non-Cash Work Cap
-5
-2
255
-41
-57
-72
-46
-17
-58
+ (Inc) Dec in Accts Receiv
-2
1
-8
3
-7
-23
2
-4
-9
+ (Inc) Dec in Inventories
-3
-3
-1
-5
-5
1
-3
5
-1
+ (Inc) Dec in Prepaid Assets
- -
- -
-9
-1
1
4
-2
- -
-2
+ Inc (Dec) in Accts Payable
-2
2
6
7
4
7
-5
1
1
+ Inc (Dec) in Other
1
-1
266
-45
-49
-60
-38
-20
-47
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-35
-32
205
-150
-193
-184
-156
-95
-46
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-3
-6
-11
-19
-62
-16
-11
-4
-3
+ Acq of Fixed Prod Assets
-2
-6
-11
-19
-62
-16
-11
-4
-3
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
321
272
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
321
272
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
39
7
-470
-98
243
19
140
81
41
+ Dec in LT Investment
164
154
414
597
560
298
570
326
223
+ Inc in LT Investment
-125
-147
-884
-695
-317
-279
-430
-244
-182
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
36
1
-482
-117
181
3
130
78
38
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
124
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
124
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
50
1
-1
21
27
8
2
- -
30
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
50
1
320
294
27
132
2
- -
30
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
52
-30
44
27
16
-49
-24
-17
22
EBITDA
-38
-44
-71
-144
-195
-179
-179
-136
-39
EBITDA Margin (%)
-98.42
-78.61
-82.99
-146.72
-126.35
-96.74
-105.34
-76.05
-14.19
Free Cash Flow
-37
-39
194
-168
-254
-200
-167
-99
-49
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-39
194
-168
-254
-76
-167
-99
-49
Free Cash Flow per Basic Share
-0.35
-0.36
2.81
-1.28
-1.81
-1.41
-1.16
-0.67
-0.32
Price/Free Cash Flow
- -
- -
9.55
-59.28
-30.07
-6.5
-4.86
-9.64
-57.27
Cash Flow to Net Income
0.81
0.69
-2.99
1.02
0.93
0.92
0.69
0.6
0.77
Capital Expenditures
-3
-6
-11
-19
-62
-16
-11
-4
-3